William E. Boden, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

I am ABIM board-certified in both Internal Medicine and the subspecialty of Cardiovascular Disease. Since 1979, I have held university appointments at Brown University, Wayne State University, Tufts New England Medical Center, Boston University, the University of Connecticut, State University of New York in Buffalo, and Albany Medical College. For the past 27 consecutive years, I have held leadership roles as either a Chief of cardiology or Chief of Medicine at both federal VA facilities and in the academic private sector, all of which have had strong affiliations with their respective academic health centers. In 2016, I re-joined the VA Boston MAVERIC Center as the Scientific Director, Clinical Trials Network, for the VA New England Healthcare System, and as the Research Lead Physician, for VISN 1.

I have extensive prior experience in clinical trials and comparative effectiveness research, and have served in a leadership capacity in several important national and international clinical trials, including as Study Chair for VA CSP-funded VANQWISH and COURAGE Trials, as Study Co-Chair of the NIH-funded AIM-HIGH Trial, and as a national co-PI for the NIH-funded ISCHEMIA Trial. My principal research interests include studies in stable ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and preventive cardiology.

Publications

  • Published 2/23/2026

    Gorog DA, de Silva R, Boden WE. The year in cardiovascular medicine 2025: the top 10 papers in ischaemic heart disease. Eur Heart J. 2026 Feb 23. PMID: 41725250.

    Read at: PubMed

  • Published 2/19/2026

    Chiu N, Bhatt DL, De Caterina R, Doenst T, Kirov H, Dayan V, Faxon DP, Kaul S, Perera D, Puskas JD, Steg PG, Boden WE. Invasive and medical management approaches to non-acute myocardial ischaemic syndromes. Nat Rev Cardiol. 2026 Feb 19. PMID: 41714707.

    Read at: PubMed

  • Published 12/30/2025

    Lopes MS, Boden WE. Early combination therapy for angina pectoris: How COMBINE offers new management insights to an old drug. Int J Cardiol. 2026 Mar 15; 447:134133. PMID: 41478451.

    Read at: PubMed

  • Published 9/14/2025

    Kawczynski MJ, Barili F, Brophy JM, De Caterina R, Biondi Zoccai G, Anselmi A, Boden WE, Parolari A, Heuts S. Revascularisation strategies for non-acute myocardial ischaemic syndromes. Heart. 2025 Sep 14. PMID: 40947142.

    Read at: PubMed

  • Published 9/5/2025

    Huded CP, Spertus JA, Jones PG, O'Brien SM, Mark DB, Bangalore S, Stone GW, Williams DO, White HD, Boden WE, Reynolds HR, Hochman JS, Maron DJ. Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA. Circulation. 2025 Sep 23; 152(12):846-858. PMID: 40910165.

    Read at: PubMed

Other Positions

  • Lecturer in Medicine
    Harvard Medical School
  • Physician Research Lead & Scientific Director, MAVERIC Center
    VA Boston Healthcare System

Education

  • State University of New York at Brockport, MD
  • Le Moyne College, BS